Institutions / Prosight Management, LP / Holdings

Prosight Management, LP

All holdings · as of Dec 31, 2025

Company	Class	Value	Shares	% of portfolio
Rein Therapeutics, Inc.	—	$513.4K	442,600	0.1%
PLIANT THERAPEUTICS, INC.PLRX	Common Stock	$1.90M	1,555,744	0.4%
TrueBlue, Inc.	—	$2.01M	442,554	0.4%
Tempus AI, Inc.	—	$2.07M	35,000	0.4%
Adicet Bio, Inc.	—	$2.11M	250,244	0.4%
ABIVAX SA	—	$2.29M	17,000	0.5%
BridgeBio Pharma, Inc.	—	$2.29M	30,000	0.5%
OnKure Therapeutics, Inc.	—	$2.37M	816,909	0.5%
ORTHOPEDIATRICS CORPKIDS	Common Stock	$2.43M	136,741	0.5%
ROCKET PHARMACEUTICALS, INC.	—	$2.61M	743,942	0.5%
Terns Pharmaceuticals, Inc.	—	$3.84M	95,000	0.8%
CareDx, Inc.	—	$4.71M	250,000	1.0%
Tectonic Therapeutic, Inc.TECX	Common Stock	$4.90M	235,000	1.0%
Corbus Pharmaceuticals Holdings, Inc.CRBP	Common Stock	$5.57M	683,872	1.2%
Immunovant, Inc.IMVT	Common Stock	$6.19M	243,404	1.3%
Alnylam Pharmaceuticals Inc	—	$6.80M	17,109	1.4%
GeneDx Holdings Corp.	—	$7.15M	55,000	1.5%
LABCORP HOLDINGS INC.	—	$8.66M	34,532	1.8%
Shattuck Labs, Inc.STTK	Common Stock	$8.69M	2,381,502	1.8%
Avantor, Inc.	—	$10.30M	898,499	2.1%
Crinetics Pharmaceuticals, Inc.	—	$12.24M	262,904	2.5%
Roivant Sciences Ltd.	—	$13.61M	627,162	2.8%
ZYMEWORKS INC.	—	$13.97M	530,393	2.9%
Syndax Pharmaceuticals Inc	—	$13.97M	665,000	2.9%
Select Medical Holdings Corp	—	$15.37M	1,035,086	3.2%
AMICUS THERAPEUTICS INC	—	$16.38M	1,150,000	3.4%
Phreesia, Inc.	—	$16.53M	977,152	3.4%
CONCENTRA GROUP HOLDINGS PAR	—	$17.54M	891,030	3.6%
BOSTON SCIENTIFIC CORP	—	$20.02M	210,000	4.1%
ICON plc	—	$20.04M	110,000	4.1%
VEEVA SYSTEMS INC	—	$20.12M	90,133	4.2%
NEKTAR THERAPEUTICS	—	$23.45M	554,633	4.8%
MEIRAGTX HLDGS PLC	—	$25.52M	3,209,788	5.3%
Kura Oncology, Inc.	—	$26.28M	2,529,600	5.4%
ADC THERAPEUTICS SA	—	$29.93M	8,477,338	6.2%
Janux Therapeutics, Inc.	—	$33.02M	2,392,523	6.8%
GALAPAGOS NV	—	$35.12M	1,074,112	7.3%
PROCEPT BioRobotics Corp	—	$43.41M	1,380,000	9.0%